Institut de Cancérologie de l'Ouest René Gauducheau
Saint-Herblain, 44805, France
NCT Number: NCT04343820
Breast implants associated with the installation of a complementary matrix (of dermal or synthetic origin), showed satisfactory results in term of post-operative follow-up but also aesthetic outcomes.
The objective of the subcutaneous positioning of this implant, is to reduce the muscular pain related to the stretching of the muscular muscle, the deformations related to the muscular contraction with an animation of the prothesis, but also the risk of hull when associated with a matrix. It also pursues the objective, of obtaining a better aesthetic result, by systematically coupling at least one lipo-modelling session.
For a long time, patients with a history of mastectomy and radiotherapy benefited from secondary breast flap reconstruction, in order to reduce the risk of complications and achieve a satisfying aesthetic outcome. But the lipo-filling technique allowed to reconsider the management of these patients.
The benefits of fat tissue transplants are know to improve tissue trophicity (flexibility, thickness, vascularization).
The objective of this study, is to evaluate the feasibility of secondary breast reconstructions by prepectoral positioned implant after lipo-preparation of the wall.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Saint-Herblain, 44805, France
60 women who have had a mastectomy and want a secondary breast reconstruction by implant at Institut de Cancérologie de l'Ouest well be included in this study.
Patients will be recruited in consultation before the start of reconstruction and up to 18 months after radiation therapy.
They will be followed for 24 months from the end of the breast reconstruction.
The following data will be collected indirectly from the clinical medical record (letters, reports of examinations, consultations, surgical report, hospitalization) of the patient, supplemented if necessary by specific records (radiotherapy records, chemotherapy, physiotherapy management) :
Clinicians at Institut de Cancérologie de l'Ouest may be asked to complete the previous informations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Breast reconstruction by prepectoral positioned implant after lipo-preparation of the wall.
Time frame: 12 months
Pre-surgical implant positioning failure at 12 months. A failure will be defined by the occurence of at least one of the following complications : documented infection ; red breast syndrome ; hematoma ; lymphocele ; delayed healing ; prothesis removal ; stage 1 hull (Baker classification) ; prothesis rotation ; waves / folds ; muscle contractions with prothesis animation ; pain (EVA 4 or 5)
Time frame: 6 months, 12 months and 24 months
Aesthetic result will be assessed by giving a mark from 0 to 5 for the following categories : general breast appearance ; breast curve ; breast consistency ; breast volume Both clinician and patient will complete the evaluation.
Time frame: 24 months
Patient satisfaction and quality of life will be assessed from Breast Q. The evaluation criteria will be the Breast Q score 24 months after the intervention.
Institut Cancerologie de l'Ouest
Other
Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation : Feasibility, Complications, Evaluation of Aesthetic Result and Quality of Life.
Acronym: RM2prepec
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05376644
Breast Cancer Female, Breast Diseases
Tomsk, Russia
View Trial DetailsNCT05203497
Breast Cancer Female, Breast Diseases
Tomsk, Russia
View Trial DetailsNCT05695859
Breast Cancer Female, Breast Diseases
Tomsk, Russia
View Trial DetailsNCT04746638
Breast Cancer Female, Breast Diseases
Tomsk, Russia
View Trial Details